所有實體腫瘤
Cancer Type
腫瘤組織（FFPE）
Specimen Requirements
2-4 個工作天
Turnaround Time ¹
ACT Nonet™ 是一款特製的 RT-PCR 腫瘤組織檢測。它涵蓋了 11 個基因的 167 個變異，這些變異有美國 FDA 批准的靶向治療。包括所有 NCCN 指引建議的基因和具有高靈敏度的特性（1~5% of DNA, 125 copies/reaction for RNA）。
RT-PCR Customizable Tissue Panel
167
Variants
11
Specially Curated Genes
≥99.9%
Clinical sensitivity & specificity
Hallmarks of ACT Nonet™
優化
省時、省成本、節省組織切片
創新
包含 NCCN 指南推薦的基因
廣泛
涵蓋具有美國 FDA 核准的靶向治療的基因
Summary
•Thetest can detect the presence of 167 hotspot genetic alterations
•Limit of detection: 1-5% DNA mutation; 300 copies for RNA fusion
•Analytical sensitivity: >99.9%; Analytical specificity: >99.9%
Technical Specifications
RT-PCR
167 variants of 11 genes
Specimen Requirements2
Tumor tissue (FFPE)
Target Genes
ALK, ROS1, RET1, NTRK1/2/3, MET, EGFR, BRAF, KRAS, HER2
Documentation
Disclaimers / Footnotes
- Turnaround time starts from the date of receipt of approved samples at our CAP-accredited laboratory.
- Please refer to our specimen instructions.
